Dr. Padula is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UH Seidman Cancer Center
2075 Healthway Dr UH Avon Health Center, 1st Fl
Avon, OH 44011Phone+1 440-517-9000Fax+1 216-201-5978
Summary
- Dr. Gilbert D. A. Padula is a highly experienced Radiation Oncologist based in Avon, OH, with subspecialties in Breast Cancer and Head & Neck Oncology. His education includes a medical degree from Michigan State University College of Human Medicine, an internship at St Joseph Mercy Ann Arbor, and residency at Memorial Sloan Kettering Cancer Center. He served as Chief Medical Officer at University Hospitals St. John Medical Center and held academic positions at Michigan State University College of Human Medicine, where he continues to contribute as a Clinical Professor. Dr. Padula has extensive experience in clinical research, clinical protocols, and neoplasm staging, among other areas. He is also a published author with several influential papers to his credit and has led numerous clinical trials. His work has been recognised with prestigious honours, including the Platinum Award for Clinical Trial Accrual from the National Cancer Institute and the Alpha Omega Alpha.
Education & Training
- Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 1988 - 2002
- St Joseph Mercy Ann ArborInternship, Transitional Year, 1997 - 1998
- Michigan State University College of Human MedicineClass of 1997
Certifications & Licensure
- MI State Medical License 2002 - 2027
- OH State Medical License 2017 - 2026
- PA State Medical License 2016 - 2021
- NY State Medical License 1999 - 2002
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Platinum Award for Clinical Trial Accrual National Cancer Institute (NCI)
- Alpha Omega Alpha
Clinical Trials
- Cytogenetic Studies in Acute Leukemia and Multiple Myeloma Start of enrollment: 1984 Jun 01
- Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer Start of enrollment: 2005 Mar 01
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery Start of enrollment: 2007 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 43 citationsNormalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer.Gilbert D.A. Padula, Michael J. Zelefsky, Ennapadam Venkatraman, Zvi Fuks, Henry J. Lee
International Journal of Radiation Oncology, Biology, Physics. 2002-02-01 - 30 citationsPhase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II).John D. Hainsworth, Kevin P. Becker, Tarek Mekhail, Sajeel A. Chowdhary, Janice Faulkner Eakle
Journal of Neuro-Oncology. 2019-08-07 - 329 citationsThe relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.Fabio Maria Vecchio, Vincenzo Valentini, Bruce D. Minsky, Gilbert D.A. Padula, Ennapadam Venkatraman
International Journal of Radiation Oncology, Biology, Physics. 2005-07-01
Grant Support
- NCI NCORP GrantNCI2015–2017
- NCI-CCOP GrantNational Cancer Institute (NCI)2011–2015
Committees
- Cancer Care Delivery Research Committee (CCDR), NRG Oncology 2015 - Present
- Publications Committee, NRG Oncology 2014 - Present
Professional Memberships
- Member
- Member
Other Languages
- Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: